Einzeltreffer — DigiBib

Lung cancer is one of the malignant tumors with the highest incidence and mortality rate in China, and its occurrence and development mechanism and treatment methods are the current research focuses. In recent years, the emergence of drugs targeting various tumor driver genes has significantly improved patients' survival and quality of life, setting off a wave of research on new therapeutic targets. Among them, long non-coding RNA (lncRNA) plays a crucial role in the malignant behavior of tumors, which has attracted widespread attention. Shown by a large number of studies, partial members of lncRNA small nucleolar RNA host gene (SNHG) family are aberrantly expressed in many maliglant tumors including non-small cell lung cancer (NSCLC) and participate in cell proliferation, invasion and migration, which may act as a new diagnostic and prognostic biomarker and can be a therapeutic target of NSCLC. In this review, we comprehensively summarize and explore the recent investigation of SNHGs in NSCLC in order to provide new ideas for the diagnosis and treatment of NSCLC. .

Titel:	[Research Progress of LncRNA SNHGs in Regulating the Biological Behavior  of Non-small Cell Lung Cancer].
Autor/in / Beteiligte Person:	Cao, X ; Chen, L
Link:	Full Text Finder (Volltext)
Zeitschrift:	Zhongguo fei ai za zhi = Chinese journal of lung cancer, Jg. 26 (2023-11-20), Heft 11, S. 851-862
Veröffentlichung:	2008- : Tianjin Shi : Zhongguo fei ai za zhi bian ji wei yuan hui ; <i>Original Publication</i>: Chendu Shi : Zhongguo fei ai za zhi bian ji wei yuan hui, 2023
Medientyp:	academicJournal
ISSN:	1999-6187 (electronic)
DOI:	10.3779/j.issn.1009-3419.2023.102.41
Schlagwort:	Humans Quality of Life China Cell Proliferation genetics Gene Expression Regulation, Neoplastic Cell Movement Cell Line, Tumor Carcinoma, Non-Small-Cell Lung pathology Lung Neoplasms pathology RNA, Long Noncoding genetics MicroRNAs genetics
Sonstiges:	Nachgewiesen in: MEDLINE Sprachen: Chinese Publication Type: Review; English Abstract; Journal Article Language: Chinese [Zhongguo Fei Ai Za Zhi] 2023 Nov 20; Vol. 26 (11), pp. 851-862. MeSH Terms: Carcinoma, Non-Small-Cell Lung* / pathology ; Lung Neoplasms* / pathology ; RNA, Long Noncoding* / genetics ; MicroRNAs* / genetics ; Humans ; Quality of Life ; China ; Cell Proliferation / genetics ; Gene Expression Regulation, Neoplastic ; Cell Movement ; Cell Line, Tumor References: Cell Death Discov. 2022 Dec 9;8(1):485. (PMID: 36494339) ; Oncol Rep. 2017 Jun;37(6):3527-3535. (PMID: 28440439) ; Thorac Cancer. 2020 Dec;11(12):3510-3520. (PMID: 33089952) ; Methods Mol Biol. 2010;596:251-90. (PMID: 19949928) ; Onco Targets Ther. 2018 Sep 20;11:6081-6090. (PMID: 30275712) ; Oncotarget. 2017 Mar 14;8(11):17785-17794. (PMID: 28147312) ; Thorac Cancer. 2020 Feb;11(2):295-304. (PMID: 31788970) ; Biomed Pharmacother. 2018 Nov;107:1434-1446. (PMID: 30257360) ; BMC Pulm Med. 2020 Oct 20;20(1):273. (PMID: 33081752) ; Biomed Pharmacother. 2019 Sep;117:109164. (PMID: 31252267) ; Cell Mol Biol Lett. 2022 Jun 3;27(1):43. (PMID: 35658874) ; Cancer Invest. 2021 Jul-Aug;39(6-7):505-513. (PMID: 33969786) ; Oncotarget. 2017 Dec 5;8(70):115754-115773. (PMID: 29383199) ; Altern Ther Health Med. 2023 May;29(4):158-163. (PMID: 36933244) ; Thorac Cancer. 2020 May;11(5):1180-1190. (PMID: 32147945) ; Biomed Pharmacother. 2020 Aug;128:110324. (PMID: 32544782) ; Bioengineered. 2022 Jan;13(1):1838-1857. (PMID: 35014944) ; Pathol Res Pract. 2022 Jun;234:153849. (PMID: 35487027) ; Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15665-70. (PMID: 9861027) ; Onco Targets Ther. 2020 Jan 30;13:921-930. (PMID: 32099396) ; Oncotarget. 2017 Dec 16;9(3):3519-3530. (PMID: 29423063) ; J Oncol. 2022 May 20;2022:2411642. (PMID: 35646120) ; Molecules. 2018 Feb 05;23(2):. (PMID: 29401721) ; J Cell Physiol. 2020 Mar;235(3):2891-2900. (PMID: 31602642) ; Biomed Pharmacother. 2019 Aug;116:108995. (PMID: 31121484) ; Cancer Manag Res. 2020 Sep 10;12:8303-8312. (PMID: 32982425) ; Adv Clin Exp Med. 2018 May;27(5):725-730. (PMID: 29790681) ; Mol Cell Biochem. 2023 Apr 29;:. (PMID: 37120495) ; Diagn Pathol. 2021 May 22;16(1):46. (PMID: 34022918) ; Cell Death Dis. 2022 Jul 28;13(7):657. (PMID: 35902569) ; Biochem Biophys Res Commun. 2020 Dec 17;533(4):1435-1441. (PMID: 33109341) ; Front Oncol. 2020 Apr 07;10:389. (PMID: 32318335) ; Eur Rev Med Pharmacol Sci. 2020 Jan;24(1):230-237. (PMID: 31957836) ; Arch Bronconeumol. 2023 Jan;59(1):10-18. (PMID: 35963709) ; Am J Transl Res. 2020 Aug 15;12(8):4456-4466. (PMID: 32913519) ; J Cell Physiol. 2019 Nov;234(11):20721-20727. (PMID: 31032916) ; Cancer Manag Res. 2019 Jun 18;11:5589-5598. (PMID: 31354360) ; Cancer Manag Res. 2020 May 07;12:3211-3222. (PMID: 32440218) ; Future Oncol. 2023 Mar 20;:. (PMID: 36935641) ; Eur Rev Med Pharmacol Sci. 2019 Aug;23(16):6935-6943. (PMID: 31486493) ; Int J Biol Macromol. 2019 Jan;121:270-278. (PMID: 30287374) ; Annu Rev Biochem. 1995;64:897-934. (PMID: 7574504) ; Am J Cancer Res. 2019 Feb 01;9(2):270-284. (PMID: 30906628) ; Biochem Biophys Res Commun. 2018 Nov 30;506(3):632-640. (PMID: 30454699) ; Oncotarget. 2017 Aug 24;8(48):84086-84101. (PMID: 29137407) ; Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211019376. (PMID: 34032148) ; Cell Biochem Biophys. 2023 Jun;81(2):325-336. (PMID: 36690880) ; Cell Death Dis. 2017 Oct 5;8(10):e3092. (PMID: 28981099) ; Biomed Pharmacother. 2019 Apr;112:108648. (PMID: 30780105) ; Cancer Manag Res. 2023 Feb 24;15:217-231. (PMID: 36873253) ; Thorac Cancer. 2020 Mar;11(3):603-611. (PMID: 31953899) ; Int J Mol Med. 2021 Aug;48(2):. (PMID: 34132359) ; Int J Mol Sci. 2021 Aug 18;22(16):. (PMID: 34445588) ; FASEB J. 2018 Jul;32(7):3957-3967. (PMID: 29466052) ; Exp Mol Pathol. 2021 Jun;120:104633. (PMID: 33753110) ; J Cell Physiol. 2018 Sep;233(9):7164-7172. (PMID: 29630731) ; Cancer Biother Radiopharm. 2021 May;36(4):360-370. (PMID: 32456448) ; Onco Targets Ther. 2018 Dec 21;12:135-146. (PMID: 30613152) ; Cell. 2019 Nov 14;179(5):1033-1055. (PMID: 31730848) ; Thorac Surg Clin. 2020 May;30(2):215-220. (PMID: 32327180) ; Indian J Cancer. 2014 Mar;51 Suppl 3:e99-e102. (PMID: 25818744) ; PLoS One. 2017 Jul 26;12(7):e0181081. (PMID: 28746345) ; Cell. 2011 Aug 5;146(3):353-8. (PMID: 21802130) ; Nat Cell Biol. 2017 Jul;19(7):820-832. (PMID: 28553938) ; Mol Ther Oncolytics. 2020 Dec 25;20:634-645. (PMID: 33816782) ; J Healthc Eng. 2021 Jul 8;2021:1643788. (PMID: 34306585) ; Biomolecules. 2020 Dec 08;10(12):. (PMID: 33302540) ; Cancer Manag Res. 2020 Sep 25;12:9113-9123. (PMID: 33061605) ; Onco Targets Ther. 2020 Nov 04;13:11327-11336. (PMID: 33177840) ; DNA Cell Biol. 2017 Nov;36(11):892-900. (PMID: 28872894) ; Biosci Rep. 2018 Aug 29;38(4):. (PMID: 29592872) ; Ann Clin Lab Sci. 2023 Jan;53(1):64-75. (PMID: 36889771) ; Thorac Cancer. 2020 May;11(5):1202-1210. (PMID: 32153123) ; J Cell Physiol. 2020 Oct;235(10):7541-7553. (PMID: 32239719) ; Oncol Lett. 2021 Dec;22(6):818. (PMID: 34671432) ; Cancer Biother Radiopharm. 2020 Jun;35(5):351-361. (PMID: 32202941) ; Kaohsiung J Med Sci. 2021 Aug;37(8):664-674. (PMID: 34002487) ; Sci Transl Med. 2011 Mar 23;3(75):75ra26. (PMID: 21430269) ; Eur Rev Med Pharmacol Sci. 2020 Sep;24(18):9522-9531. (PMID: 33015794) ; Cancer Manag Res. 2020 Aug 31;12:7941-7948. (PMID: 32943928) ; Nat Rev Clin Oncol. 2014 Aug;11(8):473-81. (PMID: 24981256) ; J Thorac Dis. 2023 Jan 31;15(1):155-167. (PMID: 36794139) ; Diagn Pathol. 2023 Mar 2;18(1):33. (PMID: 36864456) ; Front Pharmacol. 2013 Mar 14;4:28. (PMID: 23504227) ; Int J Mol Sci. 2022 Dec 01;23(23):. (PMID: 36499382) ; Immunopharmacol Immunotoxicol. 2021 Dec;43(6):693-703. (PMID: 34448661) ; Eur Rev Med Pharmacol Sci. 2018 Feb;22(3):616-622. (PMID: 29461589) ; J Thorac Oncol. 2015 Sep;10(9):1240-1242. (PMID: 26291007) ; Oncol Lett. 2019 Feb;17(2):2356-2364. (PMID: 30719111) ; Cancer Biother Radiopharm. 2020 Dec;35(10):771-775. (PMID: 32319822) ; Cell Death Dis. 2020 Jul 13;11(7):525. (PMID: 32655137) ; J Cancer. 2021 Apr 2;12(11):3291-3298. (PMID: 33976738) ; Open Biol. 2017 Sep;7(9):. (PMID: 28878044) ; Front Immunol. 2023 Mar 15;14:1143980. (PMID: 37006268) ; Eur Rev Med Pharmacol Sci. 2018 Oct;22(20):6838-6844. (PMID: 30402848) ; J Thorac Oncol. 2015 Sep;10(9):1243-1260. (PMID: 26291008) ; Am J Pathol. 2020 Jun;190(6):1343-1354. (PMID: 32201260) ; Cell Death Dis. 2021 Jan 26;12(1):128. (PMID: 33500406) ; Aging (Albany NY). 2021 Jan 8;13(2):2864-2884. (PMID: 33418541) ; J Cell Biochem. 2019 Apr;120(4):6106-6112. (PMID: 30520072) ; Cancer Lett. 2022 Feb 1;526:142-154. (PMID: 34715254) ; Int J Environ Res Public Health. 2022 Aug 12;19(16):. (PMID: 36011604) Contributed Indexing: Keywords: Long non-coding RNA; Lung neoplasms; Small nucleolar RNA host gene ; Local Abstract: [Publisher, Chinese] 【中文题目：LncRNA SNHGs调控非小细胞肺癌的 生物学行为研究进展】【中文摘要：肺癌是我国发病率和死亡率最高的恶性肿瘤之一，其发生发展机制及治疗手段是当前研究的热点。近年来，针对各种肿瘤驱动基因的分子靶向药物的出现显著提高了肺癌患者的生存率及生活质量，掀起了一波研究新型治疗靶标的热潮。其中长链非编码RNA（long non-coding RNA, lncRNA）在肿瘤的恶性行为中发挥了至关重要的作用，引起了人们的广泛关注。研究表明，lncRNA小核仁RNA宿主基因（small nucleolar RNA host gene, SNHG）家族部分成员在非小细胞肺癌（non-small cell lung cancer, NSCLC）等多种肿瘤组织中异常表达，参与肿瘤细胞的增殖、侵袭和转移等生物学过程，可能是NSCLC的诊断和预后的生物标志物，以及潜在的治疗新靶点。在这篇综述中，我们总结并探讨了SNHGs在NSCLC中的最新研究进展，以期为NSCLC的诊断及治疗提供新思路。 】【中文关键词：长链非编码RNA；小核仁RNA宿主基因；肺肿瘤】. Substance Nomenclature: 0 (RNA, Long Noncoding) ; 0 (MicroRNAs) Entry Date(s): Date Created: 20231207 Date Completed: 20231216 Latest Revision: 20231216 Update Code: 20231218 PubMed Central ID: PMC10714051

Klicken Sie ein Format an und speichern Sie dann die Daten oder geben Sie eine Empfänger-Adresse ein und lassen Sie sich per Email zusenden.

BibTeX Citavi, JabRef, u.a.
(Literaturverwaltung)

PDF kein Volltext!
(Merkzettel, Notizen)

RIS Endnote, Citavi u.a.
(Literaturverwaltung)

MODS
(XML zur Weiterverarbeitung)

oder

Wählen Sie das für Sie passende Zitationsformat und kopieren Sie es dann in die Zwischenablage, lassen es sich per Mail zusenden oder speichern es als PDF-Datei.

Gewünschter Zitations-Stil:

oder

Bitte prüfen Sie, ob die Zitation formal korrekt ist, bevor Sie sie in einer Arbeit verwenden. Benutzen Sie gegebenenfalls den "Exportieren"-Dialog, wenn Sie ein Literaturverwaltungsprogramm verwenden und die Zitat-Angaben selbst formatieren wollen.

[Research Progress of LncRNA SNHGs in Regulating the Biological Behavior of Non-small Cell Lung Cancer].

[Research Progress of LncRNA SNHGs in Regulating the Biological Behavior  of Non-small Cell Lung Cancer].